ARONTIER
Arontier is an artificial intelligence-driven drug discovery company focused on conquering incurable diseases and delivering healthy life and happiness. They integrate fundamental principles of physics with advanced machine learning algorithms to design antibodies, protein binders, peptidomimetics, and small-molecule drugs. Their technology leverages generative and language model-based methods for antibody design, de novo design of proteins with desirable functions, and AI-driven exploration of protein conformational heterogeneity for small-molecule drug design. Arontier emphasizes collaboration and innovation to accelerate drug development, aiming to make the process faster and more statistically successful.
ARONTIER
Arontier is an artificial intelligence-driven drug discovery company focused on conquering incurable diseases and delivering healthy life and happiness. They integrate fundamental principles of physics with advanced machine learning algorithms to design antibodies, protein binders, peptidomimetics, and small-molecule drugs. Their technology leverages generative and language model-based methods for antibody design, de novo design of proteins with desirable functions, and AI-driven exploration of protein conformational heterogeneity for small-molecule drug design. Arontier emphasizes collaboration and innovation to accelerate drug development, aiming to make the process faster and more statistically successful.